The addition of Dapagliflozin, sodium–glucose cotransporter-2 inhibitor to angiotensin receptorblocker-neprilysin inhibitors non-responders in patient with refractory heart failure with reduced ejection fraction

The addition of Dapagliflozin, sodium–glucose cotransporter-2 inhibitor to angiotensin receptorblocker-neprilysin inhibitors non-responders in patient with refractory heart failure with reduced ejection fraction

Show other versions (1)
Bibliographic Details
Main Authors: Pankaj Jariwala, Kartik Jadhav, Jagdish Madireddi, Anil Kulkarni, Kashyap Vyas, Arshad Punjani, Harikishan Boorougu, Dilip Babu Madhawar
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Indian Heart Journal
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483220304041

Internet

http://www.sciencedirect.com/science/article/pii/S0019483220304041

Similar Items